JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2007, 56(6):288-293

EXPERTA - the first company specializing in scientific evaluation of medicaments

L. Valášková
Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové, České farmaceutické muzeum v Kuksu

The Experta Company, specializing in scientific evaluation of medicaments, was founded in the city of Brno in 1933. Its main task was to control medicaments and mass-produced medicinal preparations, the so-called specialties, offered for their evaluation by pharmaceutical factories. The specialties were analysed using chemical, pharmacological, pharmaceutical, and biological methods. The analyses took place in the laboratories of the Medical Faculty and the Faculty of Natural Sciences, Masaryk University in Brno, and also at the College of Veterinary Surgeons in Brno. The main aim of Experta was to confirm and openly show that the composition of specialties is safe and that the medicaments could be trusted by doctors once evaluated and marked by an Experta mark. The company also made an attempt to prove that medicaments produced in our homeland are equal to those produced abroad, and hereby to support medical prescriptions of Czechoslovak remedies. All the steps taken by Experta were to contribute to economic cost savings of not only our state and health insurance companies but also to those of the patients themselves. Officially the Experta Company came to an end of its existence in 1948; however, the clouds over it darkened earlier, before the Second World War broke out. Despite the fact that Experta existed for only a relatively short period of time and that it did not implement all its aims, its conception and attempts to create in Czechoslovakia in 1934-1948 an independent controlling institute for medical specialties were remarkable and progressive (especially the emphasis on biological control of specialties).

Keywords: pharmaceutical preparations; drug control; pharmaceutical industry; proprietary medicines

Received: September 26, 2007; Accepted: October 26, 2007; Published: June 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Valášková L. EXPERTA - the first company specializing in scientific evaluation of medicaments. Čes. slov. farm. 2007;56(6):288-293.
Download citation

References

  1. Panýrek, D.: VI. sjezd československých přírodozpytců, lékařů a inženýrů v Praze. Prakt. Lék., 1928; 8, 24, 101, 137, 179, 249, 287, 318, 358, 402, 531, 561, 590, 628, 651, 692, 762, 798, 830.
  2. Moravský zemský archiv (MZA), fond B 26 Policejní ředitelství Brno, Spolky 1851-1958, krabice 3175, signatura čj. 42055/48.
  3. Bouček, B.: Vědecké hodnocení léčiv v praxi. Publikace "Experty" čís. 2. Čas. Lék. čes., 1934; 73, 219-220.
  4. Bouček, B.: Pravidla hodnocení léčiv. Tisk Experty č. 3. Čas. Lék. čes., 1934; 73, 1028-1029.
  5. Bouček, B.: Speciality v praxi a co s tím souvisí. Čas. Lék. čes., 1935; 74, 33-36.
  6. Herčík, F.: Otázka léčivých specialit. Prakt. Lék., 1934; 14, 119-120.
  7. Herčík, F., Štefl, J.: Preparáty hodnocené Expertou. Prakt. Lék., 1935; 15, 76-77. Go to original source...
  8. Starkenstein, E.: Hospodárné předpisování léčiv. Prakt. Lék., 1928; 8, 749-753, 787-792.
  9. Kaucký, J.: Situace našeho chemicko-farmaceutického průmyslu a jeho uplatnění v našem hospodářství. Revue plán, 1933; 2, 237-241.
  10. Štefl, J.: Seznam speciálních léčiv, která se nedají nahradit magistrálním předpisem a jsou těžko nahraditelná. Prakt. Lék., 1936; 16, 308-309.
  11. Bouček, B.: Hodnocení léčiv. Styk, 1934; 1, 3-5.
  12. Sbírka československých průmyslových specialit, České farmaceutické muzeum, HVLP-LH: Femidyn inj. 150, 1612, gtt. 158; Pitoxydyn 149, 1921; Uropellin 177.
  13. Skarnitzl, E.: Vývoj a úkoly kontroly léčiv v našem státě. Českoslov. Farm., 1956; 5, 6-13.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.